Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
Marcel Walser, Sylvia Rothenberger, Daniel L. Hurdiss, Anja Schlegel, Valérie Calabro, Simon Fontaine, Denis Villemagne, Maria Paladino, Tanja Hospodarsch, Alexandra Neculcea, Andreas Cornelius, Patricia Schildknecht, Mirela Matzner, Martin Hänggi, Marco Franchini, Yvonne Kaufmann, Doris Schaible, Iris Schlegel, Chloe Iss, Thamar Looser, Susanne Mangold, Christel Herzog, Dieter Schiegg, Christian Reichen, Filip Radom, Andreas Bosshart, Andreas Lehmann, Micha A. Haeuptle, Alexander Zürcher, Toni Vagt, Gabriel Sigrist, Marcel Straumann, Karl Proba, Niina Veitonmäki, Keith M. Dawson, Christof Zitt, Jennifer Mayor, Sarah Ryter, Heyrhyoung Lyoo, Chunyan Wang, Wentao Li, Ieva Drulyte, Wenjuan Du, H. Kaspar Binz, Leon de Waal, Koert J. Stittelaar, Sarah Taplin, Seth Lewis, Daniel Steiner, Frank J.M. van Kuppeveld, Olivier Engler, Berend-Jan Bosch, Michael T. Stumpp, Patrick Amstutz
bioRxiv 2020.08.25.256339; doi: https://doi.org/10.1101/2020.08.25.256339